Hemodialysis, erythropoietin and megakaryocytopoiesis: factors in uremic thrombocytopathy and thrombophilia.
Zwaginga
J J
JJ
Department of Hematology, Academical Medical Center, Department of Experimental Immunohematology, Sanquin Research at CLB, Amsterdam, The Netherlands. j.j.zwaginga@amc.uva.nl
D001791:Blood Platelet Disorders; D001792:Blood Platelets / Q000378:metabolism; D002154:Calpain / Q000378:metabolism; D020169:Caspases / Q000378:metabolism; D003956:Dialysis; D004921:Erythropoietin / Q000097:blood* / Q000378:metabolism; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology; D006801:Humans; D010718:Phosphatidylserines / Q000378:metabolism; D015539:Platelet Activation; D010974:Platelet Aggregation; D006435:Renal Dialysis / Q000379:methods*; D019851:Thrombophilia / Q000209:etiology*; D034061:Thrombopoiesis / Q000502:physiology*; D014511:Uremia / Q000097:blood* / Q000150:complications / Q000209:etiology*
D010718:Phosphatidylserines; D004921:Erythropoietin; D002154:Calpain; D020169:Caspases